Vericel Corp reports results for the quarter ended in March - Earnings Summary

Vericel

08/05/2024 15:40

* Vericel Corp  VCEL.OQ  reported a quarterly adjusted loss
of 8
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -16
cents.  The mean expectation of six analysts for the quarter was
for a loss of 11 cents per share. Wall Street expected
results to range from -17 cents to -5 cents per share.
    * Revenue rose 25% to $51.28 million from a year ago;
analysts
expected $49.07 million. 
    * Vericel Corp's reported EPS for the quarter was a loss
of 8
cents​.
    * The company reported a quarterly loss of $3.86 million.
    * Vericel Corp shares had fallen by 4.8% this quarter and
gained 39.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 16.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "strong buy"

Wall Street's median 12-month price target for Vericel Corp is
$55.00 
This summary was machine generated from LSEG data May 8 at 02:40
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.11          -0.08          Beat
 Dec. 31 2023      0.17           0.26           Beat
 Sep. 30 2023      -0.12          -0.08          Beat
 Jun. 30 2023      -0.15          -0.11          Beat